Cite

HARVARD Citation

    Tatsukawa, Y. et al. (2018). Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: A pilot study. Antiviral therapy. 23 (8), p. 709. [Online]. 
  
Back to record